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Pancreatic duct obstruction, even in the absence ofbiliaryobstruction and/or bile reflux into
the pancreatic duct, can trigger acute hemorrhagic necrotizing pancreatitis. The earliest
changes are seen within acinar cells. Early derangements in acinar cell biology include
inhibition of digestive enzyme secretion and the co-localization of lysosomal hydrolases with
digestive enzyme zymogens. Under appropriate conditions, this co-localization could lead to
digestive enzyme activation within acinar cells.
INTRODUCTION
Acute pancreatitis is an inflammatory disease ofthe pancreas, which is associated
with a number of other disease processes that are, collectively, known as the
"etiologies" of pancreatitis. Included among these etiologies of acute pancreatitis
are a number ofprocesses such as trauma to the pancreas, exposure to certain drugs
or toxins, abnormalities of plasma lipoproteins, and certain infections. The vast
majority ofpatients with acute pancreatitis, however, develop their disease either in
conjunctionwith the abuse ofalcohol or, more commonly, in association with biliary
tract stone disease. The studies ofAcosta and Ledesma [1] as well as those ofothers
have clearly indicated that the acute pancreatitis which occurs in association with
biliary tract stone disease is precipitated by the passage ofstones into or through the
terminal biliary ductal system. When Acosta and Ledesma screened the stools of
patients with biliary tract stone disease who either did or did not have associated
pancreatitis, they noted the presence of gallstones in the feces of 90 percent of
patients with acute pancreatitis but only 11 percent of patients who were not
experiencing an attackofacute pancreatitis.
The events which couple passage of biliary tract stones into or through the
terminal biliary ductal system and the development of an acute inflammatory
reaction within the pancreas are not well understood. In this paper, I review the
results of studies which we have performed over the past decade in an attempt to
elucidate some of those mechanisms. We have attempted to address three areas of
uncertainty. First, we have sought to determine whether the stone which triggers the
attack of acute pancreatitis does so by causing bile reflux into the pancreatic ductal
system or, alternatively, whether that stone triggers acute pancreatitis byobstructing
the pancreatic duct. Second, we have attempted to define where, within the pan-
creas, the earliest lesion of pancreatitis develops. Third, we have tried to elucidate
the intracellular events which might precipitate acute pancreatitis by causing diges-
tive enzyme activation within the pancreas.
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THE QUESTION OF BILE REFLUX
Three theories have been proposed which might explain the mechanism by which
passage of a stone through the distal biliary ductal system might trigger acute
pancreatitis. The first was that proposed by Opie in 1901, when he reported several
patients who, at autopsy after death from acute pancreatitis, were noted to have one
or more stones impacted in the distal biliary ductal system [2]. Opie noted that, in
those patients, the obstructing stone had created behind it a "common channel"
which allowed communication between the biliary and the pancreaticductal systems,
and he reasoned that the distal obstruction might permit bile to reflux into the
pancreatic ductal system through this common channel. He suggested that bile,
refluxed into the pancreatic ductal system, would have a noxious effect on the
pancreas and precipitate acutepancreatitis. This so-called "commonchanneltheory"
has been the subject ofextensive investigation since thattime, but itsvalidityremains
controversial.
A second theory, the so-called "duodenal reflux theory," suggests that the offend-
ing stone is passed through the sphincter of Oddi and, as a result of stone passage,
the sphincter is stretched and made incompetent. Subsequent reflux of duodenal
contents containing activateddigestive enzymes from the duodenum into the pancre-
atic ductal system through the incompetent sphincter might, according to thistheory,
precipitate acute pancreatitis. This duodenal reflux theory has, in general, been
discounted as the result of the clinical observation that patients undergoing either
surgical or endoscopic sphincter ablative procedures do not routinely develop acute
pancreatitis.
A third theory has been proposed which suggests that the offending stone or,
alternatively, the edema and inflammation caused by stone passage, results in
obstruction of the pancreatic ductal system. It is believed that, with continued
secretion into the obstructed duct, ductal hypertension could result, and, by as yet
unidentified mechanisms, this process might lead to acute pancreatitis.
Since Opie's original description of the common channel theory in 1901, many
studies have clearly demonstrated that bile, injected under pressure into the pancre-
atic ductal system, can cause pancreatic injury. It has remained unclear, however,
whether it is the bile which precipitates pancreatitis under these conditions or,
alternatively, the pressure of the injection which precipitates the attack. The
importance of ductal hypertension and ductal obstruction as triggering events in
pancreatitis has been difficult to define since, for the most part, animals subjected to
pancreatic duct ligation develop pancreatic atrophy rather than acute inflammation
within the pancreas.
Recently, it has been noted that hemorrhagic necrotizing pancreatitis can be
induced in the American opossum by ligation of the terminal biliary-pancreatic
ductal system of that animal [3,4]. The American opossum has a very long extra
duodenal common biliary-pancreatic duct as well as an easily identifiable main
pancreatic ductal system. We have carried out a number ofinvestigations, using this
experimental model of pancreatitis, to determine whether or not bile reflux is
important in the development of acute pancreatitis. In these studies, four groups of
animals were prepared. In addition to a control or unoperated group, some animals
underwent ligation of the common biliary-pancreatic duct immediately adjacent to
its point ofentry into the duodenum. Because ofthe long common biliary-pancreatic
channel that the opossum has, this group of animals were exposed to pancreatic
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outflow obstruction under conditions which permitted bile reflux into the pancreatic
ductal system. Another group ofanimals underwent separate ligation ofthe bile duct
and the pancreatic duct. As a result, these animals experienced pancreatic ductal
outflow obstruction as well as extrahepatic biliary ductal obstruction under condi-
tionswhichprevented bile reflux into the pancreatic ductal system. Anothergroup of
animals underwent ligation of the pancreatic duct alone without accompanying bile
duct obstruction. Finally, a jaundiced control group of animals were prepared, in
which only the bile duct was obstructed.
Hemorrhagic necrotizing pancreatitis developed in the animals subjected to
pancreatic duct obstruction with, aswell aswithout, accompanying bile duct obstruc-
tion. In addition, hemorrhagic necrotizing pancreatitis developed in the animals
undergoing ligation of the combined biliary-pancreatic duct adjacent to the duode-
num. When careful morphometric examination of the severity of pancreatitis was
carried out, we noted that the severity of pancreatitis was similar in each of these
three groups.
We concluded, from these studies, that pancreatic duct obstruction is, by itself,
sufficient to induce severe necrotizing hemorrhagic pancreatitis in the American
opossum. The presence of accompanying bile duct obstruction does not appear to
worsen the severity of pancreatitis in these animals. Potentially more significant,
however, was our observation that ligation of the common biliary pancreatic ductal
system of the opossum, a procedure which causes pancreatic duct obstruction while
permitting bile reflux into the pancreas, does not result in pancreatitis that is more
severe than that noted after isolated pancreatic duct obstruction under conditions
which prevent bile reflux. This observation has led us to conclude (a) that bile reflux
is not required for the development ofacute necrotizingpancreatitis and (b) thatbile
reflux does not worsen the acute pancreatitis which follows pancreatic duct obstruc-
tion [5].
LOCATION OF THE EARLIEST LESIONS
The location of the earliest lesions of pancreatitis has been the subject of
considerable controversy. Studies of early pancreatitis in humans have been unable
to answer this question because the clinical disease is usuallyfar advanced before the
pancreas can be examined morphologically. Kloppel et al. have suggested that the
earliest lesions ofpancreatitis develop in the peripancreatic connective tissue and in
the perilobular regions of the pancreas [6]. In contrast, Foulis [7] has argued that
acute pancreatitis develops in the periductal area ofthe pancreas. In orderto explore
this question further, we have studied the very earliest events which occur after
ligation of the pancreatic ductal system of the opossum. As noted above, ligation of
the ductal system in the opossum leads to severe hemorrhagic necrotizing pancreati-
tis. Gross changes are noted within three days ofduct ligation in that animal and, by
14 days, most ofthe animals have died ofacute necrotizingpancreatitis. We studied a
group of animals which had been subjected to combined biliary-pancreatic ductal
obstruction for three, six, 12, and 24 hours. We noted that acinar cell necrosis could
be detectedwithin three hours ofduct ligation and that areas ofnecrosis increased in
size over the ensuing 12 hours. Widespread patchy areas of acinar necrosis could
easily be detected microscopically within 12 hours of duct ligation, yet, at that time,
no evidence ofeither periductal or perilobular inflammation was found. By 24 hours
following duct ligation, early changes ofperiductal inflammation could be seen. We
423MICHAEL L. STEER
concluded, from these studies, that the earliest changes in this model of acute
pancreatitis occur within the acinar cells themselves and that neither periductal nor
perilobular changes were, in fact, the earliest lesions ofthe disease [8].
PREMATURE DIGESTIVE ENZYME ACTIVATION
There are several pieces of circumstantial evidence which have suggested that
acute pancreatitis results from autodigestion of the gland by enzymes which are
normally synthesized and secreted by the pancreas. That evidence includes the fact
that the pancreas does, indeed, synthesize a large amount of digestive enzyme
protein. In addition, during acute clinical pancreatitis, activated forms of digestive
enzymes have been detected within the pancreas itself. Finally, the morphological
changes of severe acute pancreatitis suggest that a coagulation necrosis or digestive
process has occurred. Although this evidence has suggested that pancreatitis may
involve digestion of the gland parenchyma, the mechanisms responsible for that
process have evaded elucidation. Indeed, the pancreas does synthesize a large
amount of protein, and the vast majority of that protein is composed of digestive
enzymes that are secreted from the acinar cells of the pancreas. Most of those
digestive enzymes, however, are synthesized and secreted as inactive proenzymes or
zymogens, with normal activation occurring only after they reach the duodenum,
where the brush border enzyme enterokinase (enteropeptidase) activates trypsino-
gen, and trypsin activates the remaining digestive enzymes. Thus, an explanation of
the mechanisms leading to digestion of the pancreas during acute pancreatitis must
include a mechanism whereby those digestive enzymes might become activated
within the gland itself.
ExperimentalModels
Inorder to studythe early events ofacute pancreatitis, we have taken advantage of
three recently developed models ofthe disease. The first model is that developed by
Lombardi and co-workers [9], who noted that feeding young female mice a diet
which was choline-deficient yet enriched in ethionine (the CDE diet) could cause
hemorrhagic pancreatic necrosis which, if the diet was fed continuously, was uni-
formly fatal within five days. For our own studies, we have modified the protocol
originally developed byLombardi and co-workers so as to induce aslightlymoremild
disease and one which would be easily manipulable during the early stages. We have
used young female mice weighing between ten and 14 grams and fasted those mice
for 24 hours prior to exposing them to the CDE diet. After being fed three grams of
the diet permouse over a 24-hour period, the mice are once again fasted for 24 hours
and then placed back on normal laboratory chow. Using this protocol, a five-day
mortality rate ofbetween 50 and 70 percent can be attained. Little or no evidence of
gross injury to the pancreas can be detected within the first two or three days ofthis
experimental protocol.
We have also employed a model of pancreatitis which is less severe than that
induced by the choline-deficient, ethionine-supplemented diet. That model, origi-
nally developed by Lampel and Kern [10], involves infusing rats with a dose of the
CCK analog caerulein in excess ofthat dose which elicits a maximal rate ofdigestive
enzyme secretion. This so-called "supramaximal stimulation" elicits a transient,
reversible, and non-fatal form ofedematous pancreatitis. Edema canbe notedwithin
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one hour of the beginning of the infusion, and, in general, the lesion regresses over
the subsequent several days after cessation ofthe infusion.
The final model that we have employed represents an attempt to duplicate the
events that follow pancreatic duct obstruction. We have used both rats and rabbits
for these experiments. To duplicate ductal obstruction, we have cannulated the
pancreatic duct and subsequently elevated the indwelling cannula to a vertical
position so that the animal secretes juice into the cannula until the hydrostatic
pressure ofthe column ofsecretedjuice matches the secretory pressure ofthe gland.
At that time, the duct is functionally obstructed [11].
We have noted that each of these three models, although strikingly different in
terms of the actual manipulations occurring and the severity of pancreatitis which
results, brings about a remarkably similar constellation ofchanges. All three models
cause demonstrable pancreatic edema as well as marked hyperamylasemia. In our
subsequent studies, we have attempted to identify other features which might be
common to all three of these models in the belief that those events that might be
common in such otherwise dissimilar models ofpancreatitis might also be important
in the clinical disease. We have focused our attention on the events related toprotein
and digestive enzyme synthesis as well as intracellular transport within the pancreas
because of the circumstantial evidence mentioned above, which has suggested that
acute pancreatitis might result from autodigestion ofthe gland.
DigestiveEnzyme Synthesis and Secretion
Our initial studies focused on the processes of digestive enzyme synthesis and
secretion from the pancreas. The acinar cell of the pancreas is the most active
protein-synthesizing cell in the body and over 90 percent of the protein synthesized
bythe pancreas isdigestive enzymeprotein destined tobe exported fromthe cell. We
have employed the pulse label technique to evaluate the processes of synthesis and
secretion. The animal was given a bolus of radioactive amino acid and, at selected
subsequent times, the pancreas was removed, homogenized, and the incorporation of
radioactivity into protein measured. The rate of appearance ofradioactivity labeled
protein is, using this technique, a measure ofthe rate and extent ofprotein synthesis.
In the normal pancreas, radioactively labeled protein accumulated with time until a
maximal level was reached, and, subsequently, radioactivity declined as the newly
synthesized protein was exported from acinar cells, transported through the pancre-
atic ductal system, and discharged into the duodenum. On the other hand, in all
three of the models of pancreatitis (diet-induced, secretagogue-induced, and duct
obstruction-induced), although digestive enzyme synthesis was unaffected, the pro-
cess of digestive enzyme secretion was markedly reduced. We have concluded from
these studies that an early event in the evolution ofpancreatitis involves theblockade
ofdigestive enzyme secretion from acinar cells [11-13].
Intracellular Trafficking
Proteins are assembled within acinar cells on the rough endoplasmic reticulum.
The nascent polypeptide chains elongate within the cisternae of the endoplasmic
reticulum, and, after synthesis has been completed, the newly synthesized proteins
are transported to the Golgi complex. Most of the current evidence indicates that
protein sorting occurs primarily in the Golgi complex. Some enzymes, such as those
destined to be transported to lysosomes, are glycosylated in the Golgi complex, while
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others undergo other post-translational modifications. Proteins such as digestive
enzymes, which are destined to be exported from the cell, are believed to pass
through the Golgi complex and are packaged in zymogen granules which mature into
condensing vacuoles as they move to the luminal surface of the cell. At the luminal
surface, and in response to hormonal stimulation, the limiting membrane of the
zymogen granule fuses with the luminal plasma membrane, and, as a result, the
contents of the zymogen granule are discharged into the extracellular ductal space
[14]. Subsequent to their being glycosylated, lysosomal enzymes are modified by
phosphorylation at the 6 position of mannose residues. The 6-mannose-phosphorylat-
ed proteins are bound by mannose-6-phosphate-specific receptors in the Golgi,
which then shuttle between the Golgi complex and the pre-lysosomal compartment,
transporting lysosomal enzymes away from the secretory pathway and into the
lysosomal compartment [15].
We were particularly interested in the possibility that a defect in sorting of
digestive enzymes and lysosomal enzymes might occur during the early stages of
pancreatitis because of previously reported evidence that the lysosomal enzyme
cathepsin B could, under certain conditions, cause the activation of tryp3inogen
[16,17]. Since trypsin is capable of activating the remaining zymogens, intracellular
activation oftrypsinogen by cathepsin B could eventually lead to activation of most of
the digestive enzymes.
In order to evaluate possible changes in the intracellular trafficking of digestive
enzymes and lysosomal enzymes, we have employed the techniques of subcellular
fractionation as well as immunolocalization [18-21]. In our subcellular fractionation
studies, the pancreas was removed, homogenized, and then subjected to varying
degrees of centrifugal force. As a result, a high-density zymogen granule pellet was
obtained, a somewhat lower-density pellet enriched in lysosomes and mitochondria
was obtained, and, finally, a microsomal as well as a soluble fraction was obtained
after high-speed centrifugation. As expected, most of the digestive enzyme protein
was recovered in the zymogen granule fraction, and more than 50 percent of the
lysosomal enzyme activity was detected in the lysosome-mitochondrial fraction.
Approximately 20 to 25 percent of the lysosomal enzyme activity was also recovered
in the zymogen granule fraction under normal conditions, a phenomenon which was
initially interpreted as indicating the presence of relatively high-density lysosomes.
More recent studies, however, have indicated that a significant fraction of lysosomal
enzymes normally escape complete sorting in the Golgi complex and, as a result, that
fraction of lysosomal enzymes is packaged in the secretory vesicles of the secretory
pathway [22]. We have noted that there is a marked increase in the amount of
lysosomal enzyme which is recovered in the zymogen granule fraction during the
early stages of all three models of experimental pancreatitis, and, at the same time,
there is a corresponding reduction in the amount of lysosomal enzyme recovered in
the lysosomal fraction in those models. This observation strongly suggests that
mis-sortingoflysosomal enzymes might occur during the early stages ofexperimental
pancreatitis and that, as a result, lysosomal enzymes and digestive enzymes might
become co-localized within the same intracellular organelles. Other interpretations
of the results of subcellular fractionation experiments are certainly possible, how-
ever, including the fact that the enzymes might be recovered within the same fraction
yet not occupy the same organelle. To complement our subcellular fractionation
studies, therefore, we have also employed morphological techniques ofimmunolocal-
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ization. Using this approach, samples were obtained from the pancreas during the
early stages of experimental pancreatitis, and those samples were examined, using
antibodies directed against lysosomal enzymes as well as antibodies directed against
digestive enzymes. At both the light and the electron microscopic level, we have been
able to detect the presence of digestive enzymes and lysosomal enzymes within the
same intracellular organelles during the early stages of these forms of pancreatitis,
whereas no such co-localization could be detected in normal animals. These observa-
tions, combined with those noted from our subcellular fractionation studies, have led
us to conclude that co-localization of digestive enzymes and lysosomal enzymes
occurs during the early stages ofacute experimental pancreatitis. We have also noted
that the fragility of the lysosomal enzyme-containing organelles is increased during
these early stages ofexperimental pancreatitis.
In an overall sense, our studies have suggested the following model, which might
be a valid explanation for the early events that underlie the development of acute
pancreatitis. We would suggest that an early event in the evolution of pancreatitis
results in the blockade of digestive enzyme secretion from the acinar cell. By
mechanisms that are not completely understood, that blockade ofsecretion results in
an alteration in intracellular sorting and trafficking of newly synthesized proteins,
and, as a result, digestive enzyme zymogens become co-localized with lysosomal
hydrolases within the same intracellular organelles. We believe that this co-
localization might lead to intra-acinar cell activation of digestive enzymes and that,
because the organelles containing these enzymes become increasingly fragile, rup-
ture ofthe organelles might release activated digestive enzymes within the cytoplas-
mic space ofthe acinar cell. Such an event could, we believe, lead to acinar cell injury
[23].
Mechanistic Studies
Acinar cells of the pancreas normally secrete their stored digestive enzymes in
response to neurohumoral stimulation. The neurotransmitter acetylcholine and the
hormone cholecystokinin (CCK) bind to cell surface receptors and trigger intracellu-
lar events that result in the discharge of stored digestive enzymes into the ductal
space. This process, collectively known as stimulus-secretion coupling, involves a
number of events that occur in sequence. Subsequent to hormone receptor binding,
activation of the membrane-bound enzyme phospholipase C occurs in a GTP-
dependent manner and, as a result, membrane phospholipids such as PIP2 are
hydrolyzed. The products of PIP2 hydrolysis are IP3 and diacylglycerol. They act as
intracellular messengers to stimulate the release ofcalcium from intracellular stores and
to activate protein kinase C. We have evaluated the changes in stimulus-secretion
coupling which occur during the early stages of diet-induced and secretagogue-
induced pancreatitis. In the diet-induced model, we found that stimulus-secretion
coupling is blocked at the level of phospholipase activation; that is, hormone
receptor binding remains normal, yet exposure to hormone fails to elicit the
generation ofIP3 or release of intracellular calcium [24]. Secretion can, under these
conditions, be restored if the block is bypassed by direct stimulation with a calcium
ionophore or by administration of a diacylgycerol analog or a phorbol ester. These
observations have suggested that the ethionine-containing diet, by as yet undefined
mechanisms, prevents the activation of phospholipase C, which normally follows
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hormone receptor occupancy. This block might, possibly, involve an alteration of
GTP-binding protein activity.
The blockade of secretion which occurs after supramaximal stimulation with
caerulein appears to involve another mechanism. Caerulein, as noted previously, is a
CCK analog, and, as a result, it can be expected to bind to cell surface CCK
receptors. Pancreatic acinar cells are believed to have both high-affinity and low-
affinity CCK receptors, with the former mediating the process of digestive enzyme
secretion, while the latter appear to have an inhibitory role in this process. Recently,
a CCK analog known as CCK-JMV-180 has been developed [25], which acts as an
agonist at the high-affinity stimulatory CCK receptors and as an antagonist at the
low-affinity inhibitory CCK receptors. We have evaluated the ability of this CCK
analog to induce pancreatitis and its effect on pancreatitis induced by caerulein.
Those studies were based on the prediction that, if pancreatitis induced by caerulein
was mediated by the high-affinity receptors, than the CCK-JMV-180 analog would
induce pancreatitis itself. On the other hand, if secretagogue-induced pancreatitis
was mediated by the low-affinity inhibitory receptors, we would predict that the
CCK-JMV-180 analog would not induce pancreatitis, but that it would inhibit
pancreatitis induced by caerulein. We have found that, indeed, CCK-JMV-180 is
incapable of inducing pancreatitis and that the analog prevents pancreatitis induced
by high doses ofcaerulein. As a result, we have concluded that secretagogue-induced
pancreatitis is mediated by the low-affinity inhibitory CCK receptors [26].
The mechanisms by which low-affinity receptor occupancy might result in a defect
in secretion as well as intracellular co-localization of digestive enzymes and lyso-
somal hydrolases is not entirely clear. Since pancreatic edema, hyperamylasemia,
and subcellular enzyme redistribution can be detected within one or two hours of
supramaximal in vivo stimulation, we reasoned that similar events might be detected
after exposing acinar cells to in vitro supramaximal stimulation. Clearly, hyperamyla-
semia and pancreatic edema cannot be measured in a system which involves in vitro
incubation of acinar cells with supramaximally stimulating doses of hormone. On the
other hand, the phenomenon of lysosomal enzyme redistribution is easily measured
under those conditions, and, we postulated, might be a useful method of following
the evolution of this "in vitro model" of acute pancreatitis. We were surprised to
note, however, that exposure of acini to supramaximally stimulating concentrations
of caerulein did not result in subcellular lysosomal enzyme redistribution. When
acini were incubated with a supramaximally stimulating concentration of caerulein
along with plasma obtained from an animal infused with a supramaximally stimulat-
ing dose of caerulein, however, subcellular lysosomal enzyme redistribution was, in
fact, noted. This observation suggests that in vivo supramaximal stimulation results in
the elaboration of a plasma factor which can, under appropriate conditions, result in
the in vitro subcellular redistribution of lysosomal enzymes. We have fractionated the
plasma used in these experiments and noted that the active factor is a protein with a
molecular weight between 10,000 and 30,000 daltons and that that protein appears to
have proteolytic enzyme activity. A similar plasma factor was also detected in
samples obtained from opossums several days after duct obstruction. Taken to-
gether, these observations have suggested that a plasma factor may be elaborated
during the early stages of pancreatitis and that this plasma factor may play an
important role in causing the intracellular biochemical changes that eventually lead
to digestive enzyme activation [27].
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FUTURE DIRECTIONS
There are a large number of questions which remain unanswered regarding the
pathogenesis and evolution of pancreatitis, both from a clinical as well as an
experimental standpoint. For example, the factors which determine the severity of
pancreatitis remain completely unknown. The models that we have used result in
markedly different severities of pancreatitis. The diet-induced model results in
massive hemorrhagic pancreatic necrosis with death ofthe animal, whereas secreta-
gogue-induced pancreatitis is a transient and mild form ofthe disease, characterized
primarily by edema and hyperamylasemia. Duct obstruction in rats and rabbits leads
to transient pancreatic edema but little evidence of inflammation, whereas duct
obstruction in the opossum appears to lead to hemorrhagic necrosis ofthe glandwith
death of the animal. In spite of these marked differences in severity and outcome,
most of the events which we have characterized were found to occur in all of these
models of pancreatitis. Clearly, other events must be superimposed on those which
we have identified, and those additional events must be important determinants of
the severity ofpancreatitis. It would be extremely important and clinically useful to
identify those events, since it is those processes which might be the target of the
therapeutic interventions. Another important area ofuncertainty involves the time-
dependence of pancreatitis. It is as yet unclear whether the severity of clinical
pancreatitis is determined at the moment of its onset or, alternatively, whether it is
determined by the duration of pancreatic duct obstruction. From a clinical stand-
point, the timing and choice oftherapy depend on resolution ofthis question. Some
have advocated early operative or endoscopic intervention to remove potentially
obstructing stones, whereasothers have concluded that theoffending stone has, most
likely, passed by the time the patient presents to the hospital and that, in any case,
the severity of pancreatitis has already been determined. Thus, resolution of this
question may have important implications on the therapeutic approach employed. It
is hoped that studies employing the models described above can answer some of
these remaining critically important questions.
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